{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:45:23Z","timestamp":1792010723105,"version":"4.4.0"},"reference-count":222,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.pharmr.2026.100161","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:41:29Z","timestamp":1789195289000},"page":"100161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medication adherence: An overlooked critical determinant of pharmacological effectiveness"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1283-8487","authenticated-orcid":false,"given":"Michel","family":"Burnier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0597-8318","authenticated-orcid":false,"given":"Michel","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9481-6067","authenticated-orcid":false,"given":"Pankaj","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslaw","family":"Kardas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7557-9278","authenticated-orcid":false,"given":"Marie-Paule","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9090-1253","authenticated-orcid":false,"given":"Bernard","family":"Vrijens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmr.2026.100161_bib1","series-title":"Global Trends in R&D: Activity, Productivity and Enablers","article-title":"Evolution of drug development: what has changed in the last 10 years?","author":"Aitken","year":"2024"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/jfmpc.jfmpc_578_19","article-title":"Trends in FDA drug approvals over last 2 decades: an observational study","volume":"9","author":"Batta","year":"2020","journal-title":"J Family Med Prim Care"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib3","first-page":"118","article-title":"Advancements in contemporary pharmacological innovation: mechanistic insights and emerging trends in drug discovery and development","volume":"3","author":"Majumder","year":"2025","journal-title":"Intell Pharm"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41591-022-02160-z","article-title":"The next generation of evidence-based medicine","volume":"29","author":"Subbiah","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmr.2026.100161_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.s855","article-title":"US pushes real time clinical trials to eliminate \u201cdead time\u201d in approvals","volume":"393","author":"Logan","year":"2026","journal-title":"BMJ"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100161_bib6","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.3390\/s25164909","article-title":"Future designs of clinical trials in nephrology: integrating methodological innovation and computational power","volume":"25","author":"Strizzi","year":"2025","journal-title":"Sensors (Basel)"},{"key":"10.1016\/j.pharmr.2026.100161_bib7","first-page":"51","article-title":"In silico clinical trials: is it possible?","volume":"2716","author":"Ars\u00e8ne","year":"2024"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100161_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068057","article-title":"Registry randomised trials: a methodological perspective","volume":"13","author":"Doherty","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharmr.2026.100161_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2147\/CLEP.S44651","article-title":"Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiology","volume":"5","author":"Thuesen","year":"2013","journal-title":"Clin Epidemiol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100161_bib10","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00125-022-05762-x","article-title":"Registry-based randomised clinical trials: a remedy for evidence-based diabetes care?","volume":"65","author":"Eriksson","year":"2022","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-pharmtox-011711-113247","article-title":"Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories","volume":"52","author":"Blaschke","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib12","first-page":"9","article-title":"The importance of assessing drug exposure and medication adherence in evaluating investigational medications: ensuring validity and reliability of clinical trial results","volume":"38","author":"Vrijens","year":"2024","journal-title":"Pharmaceut Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.pharmr.2026.100161_bib14","series-title":"Adherence to Long-Term Therapies: Evidence for Action","year":"2003"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100161_bib15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A new taxonomy for describing and defining adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100161_bib16","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"issue":"38","key":"10.1016\/j.pharmr.2026.100161_bib17","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100161_bib18","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmr.2026.100161_bib19","series-title":"Compliance With Therapeutic Regimens","author":"Haynes","year":"1976"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100161_bib20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-135-9-200111060-00012","article-title":"Clinical inertia","volume":"135","author":"Phillips","year":"2001","journal-title":"Ann Intern Med"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100161_bib21","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.2011.490","article-title":"Clinical inertia as a clinical safeguard","volume":"305","author":"Giugliano","year":"2011","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100161_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020599","article-title":"Consensus study to define appropriate inaction and inappropriate inertia in the management of patients with hypertension in primary care","volume":"8","author":"Lebeau","year":"2018","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100161_bib23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/HYPERTENSIONAHA.111.174367","article-title":"Treatment intensification in a hypertension Telemanagement trial: clinical inertia or good clinical judgment?","volume":"58","author":"Crowley","year":"2011","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pcd.2017.01.007","article-title":"Clinical inertia-Time to reappraise the terminology?","volume":"11","author":"Khunti","year":"2017","journal-title":"Prim Care Diabetes"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00592-016-0939-9","article-title":"Is there evidence of potential overtreatment of glycaemia in elderly people with type 2 diabetes? Data from the GUIDANCE study","volume":"54","author":"M\u00fcller","year":"2017","journal-title":"Acta Diabetol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08037051.2014.946787","article-title":"Physician (investigator) inertia in apparent treatment-resistant hypertension\u2014insights from large randomized clinical trials. Lennart Hansson memorial lecture","volume":"24","author":"Kjeldsen","year":"2015","journal-title":"Blood Press"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100161_bib27","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1089\/tmj.2017.0184","article-title":"Clinical inertia in a randomized trial of telemedicine-based chronic disease management: lessons learned","volume":"24","author":"Barton","year":"2018","journal-title":"Telemed J E Health"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100161_bib28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/14737167.2024.2363401","article-title":"Physician and patient adherence in hypertension trials: a point of view on an important issue to resolve","volume":"24","author":"Burnier","year":"2024","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100161_bib29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/MAJ.0b013e318068dde8","article-title":"Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review","volume":"334","author":"Gossec","year":"2007","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1740774513512565","article-title":"Adherence reporting in randomized controlled trials","volume":"11","author":"Zhang","year":"2014","journal-title":"Clin Trials"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100161_bib31","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/cpt.2709","article-title":"Medication adherence measurement methods in registration trials supporting the approval of new medicines: a cross-sectional analysis of centralized procedures in the European Union 2010-2020","volume":"112","author":"Mantila","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100161_bib32","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/ajhp\/zxab392","article-title":"Proportion of days covered as a measure of medication adherence","volume":"79","author":"Loucks","year":"2022","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib33","first-page":"CD000011","article-title":"Interventions for helping patients to follow prescriptions for medications","author":"Haynes","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100161_bib34","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1185\/03007990903126833","article-title":"Good and poor adherence: optimal cut-point for adherence measures using administrative claims data","volume":"25","author":"Karve","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100161_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006056","article-title":"Antihypertensive medication adherence and risk of cardiovascular disease among older adults: a population-based cohort study","volume":"6","author":"Yang","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100161_bib36","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/08037051.2021.1907174","article-title":"Assessment of a strategy combining ambulatory blood pressure, adherence monitoring and a standardised triple therapy in resistant hypertension","volume":"30","author":"Polychronopoulou","year":"2021","journal-title":"Blood Press"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1742-1241.2010.02616.x","article-title":"Impact of prolonged antihypertensive duration of action on predicted clinical outcomes in imperfectly adherent patients: comparison of aliskiren, irbesartan and ramipril","volume":"65","author":"Burnier","year":"2011","journal-title":"Int J Clin Pract"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100161_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002606","article-title":"Medication adherence interventions improve heart failure mortality and readmission rates: systematic review and meta-analysis of controlled trials","volume":"5","author":"Ruppar","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"32","key":"10.1016\/j.pharmr.2026.100161_bib39","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1093\/eurheartj\/ehag199","article-title":"Heart failure with reduced ejection fraction in Sweden: patient adherence and persistence to quadruple pharmacotherapy prescription","volume":"47","author":"Lindberg","year":"2026","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100161_bib40","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1002\/ejhf.70090","article-title":"Adherence to guideline-directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy","volume":"27","author":"Savarese","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pharmr.2026.100161_bib41","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3389\/fphar.2018.01290","article-title":"A systematic review of medication adherence thresholds dependent of clinical outcomes","volume":"9","author":"Baumgartner","year":"2018","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100161_bib42","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006371","article-title":"Adherence to antihypertensive medications and stroke risk: a dose-response meta-analysis","volume":"6","author":"Xu","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jan.15776","article-title":"Medication adherence trajectory of patients with chronic diseases and its influencing factors: a systematic review","volume":"80","author":"Chen","year":"2024","journal-title":"J Adv Nurs"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100161_bib44","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/ejhf.2160","article-title":"Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study)","volume":"23","author":"Gupta","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pharmr.2026.100161_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fphar.2013.00091","article-title":"Determinants of patient adherence: a review of systematic reviews","volume":"4","author":"Kardas","year":"2013","journal-title":"Front Pharmacol"},{"issue":"6-7","key":"10.1016\/j.pharmr.2026.100161_bib46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.acvd.2019.11.009","article-title":"Poor adherence to medication and salt restriction as a barrier to reaching blood pressure control in patients with hypertension: cross-sectional study from 12 sub-Saharan countries","volume":"113","author":"Macquart de Terline","year":"2020","journal-title":"Arch Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib47","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13643-019-1014-8","article-title":"Medication adherence influencing factors-an (updated) overview of systematic reviews","volume":"8","author":"Gast","year":"2019","journal-title":"Syst Rev"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100161_bib48","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/jhh.2017.48","article-title":"Factors associated with antihypertensive medication non-adherence: a systematic review","volume":"31","author":"van der Laan","year":"2017","journal-title":"J Hum Hypertens"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100161_bib49","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s11606-020-06447-0","article-title":"The impact of social determinants of health on medication adherence: a systematic review and meta-analysis","volume":"36","author":"Wilder","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/pop.2023.0238","article-title":"Expanding the catalog of patient and caregiver out-of-pocket costs: a systematic literature review","volume":"27","author":"Schmidt","year":"2024","journal-title":"Popul Health Manag"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/ijph.ijph_216_24","article-title":"Antihypertensive medication adherence and related factors among elderly hypertensive patients in China: a meta-analysis","volume":"69","author":"Liu","year":"2025","journal-title":"Indian J Public Health"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100161_bib52","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/eurheartj\/ehv641","article-title":"Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study","volume":"37","author":"Nielsen","year":"2016","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib53","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1038\/s41598-022-10070-w","article-title":"Online misinformation is linked to early COVID-19 vaccination hesitancy and refusal","volume":"12","author":"Pierri","year":"2022","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100161_bib54","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1007\/s10461-018-2157-7","article-title":"The role of HIV stigma in ART adherence and quality of life among rural women living with HIV in India","volume":"22","author":"Ekstrand","year":"2018","journal-title":"AIDS Behav"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/2049-3258-72-37","article-title":"Adherence influencing factors\u2014a systematic review of systematic reviews","volume":"72","author":"Mathes","year":"2014","journal-title":"Arch Public Health"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100161_bib56","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1007\/s11606-021-06648-1","article-title":"An adaptable framework for factors contributing to medication adherence: results from a systematic review of 102 conceptual frameworks","volume":"36","author":"Peh","year":"2021","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.pharmr.2026.100161_bib57","article-title":"Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak","volume":"4","author":"Kardas","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.pharmr.2026.100161_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1516161","article-title":"Barriers to healthcare access and continuity of care among Ukrainian war refugees in Europe: findings from the RefuHealthAccess study","volume":"13","author":"Kardas","year":"2025","journal-title":"Front Public Health"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100161_bib59","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3390\/pharmaceutics13071100","article-title":"Factors contributing to medication adherence in patients with a chronic condition: a scoping review of qualitative research","volume":"13","author":"Kvarnstr\u00f6m","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib60","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11892-023-01532-0","article-title":"Factors influencing medication adherence among adults living with diabetes and comorbidities: a qualitative systematic review","volume":"24","author":"Gow","year":"2024","journal-title":"Curr Diab Rep"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100161_bib61","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jval.2013.04.014","article-title":"A systematic literature review of psychosocial and behavioral factors associated with initial medication adherence: a report of the ISPOR medication adherence & persistence special interest group","volume":"16","author":"Zeber","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.pharmr.2026.100161_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108392","article-title":"White coat adherence effect on glucose control in adult individuals with diabetes","volume":"168","author":"Zueger","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib63","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12913-022-08023-0","article-title":"What is needed for continuity of care and how can we achieve it?\u2014Perceptions among multiprofessionals on the chronic care trajectory","volume":"22","author":"Ljungholm","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100161_bib64","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCRESAHA.118.313220","article-title":"Adherence in hypertension","volume":"124","author":"Burnier","year":"2019","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100161_bib65","first-page":"860","article-title":"Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes","volume":"30","author":"Gleason","year":"2024","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib66","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/HYPERTENSIONAHA.118.11139","article-title":"Effect of adherence to antihypertensive medication on the long-term outcome after hemorrhagic stroke in Korea","volume":"72","author":"Kim","year":"2018","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100161_bib67","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/HYPERTENSIONAHA.119.14107","article-title":"Clinical influence of nonadherence with prophylactic Aspirin in preventing preeclampsia in high-risk pregnancies: a multicenter, prospective, observational cohort study","volume":"75","author":"Shanmugalingam","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmr.2026.100161_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e3953","article-title":"Lay perspectives on hypertension and drug adherence: systematic review of qualitative research","volume":"345","author":"Marshall","year":"2012","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100161_bib69","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.pharmr.2026.100161_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1156081","article-title":"Medication adherence with fixed-dose versus free-equivalent combination therapies: systematic review and meta-analysis","volume":"14","author":"Wei","year":"2023","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib71","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/HYPERTENSIONAHA.120.15781","article-title":"Adherence to Single-Pill versus Free-equivalent combination therapy in hypertension: a systematic review and meta-analysis","volume":"77","author":"Parati","year":"2021","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100161_bib72","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/HJH.0000000000003916","article-title":"Effect of single-pill versus free equivalent combinations on persistence and major adverse cardiovascular events in hypertension: a real-world analysis","volume":"43","author":"Simonyi","year":"2025","journal-title":"J Hypertens"},{"issue":"7072","key":"10.1016\/j.pharmr.2026.100161_bib73","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/bmj.313.7072.1624","article-title":"Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness","volume":"313","author":"de Craen","year":"1996","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100161_bib74","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012586","article-title":"Impact of changes in pill appearance in the adherence to angiotensin receptor blockers and in the blood pressure levels: a retrospective cohort study","volume":"7","author":"Lumbreras","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100161_bib75","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/pharmaceutics12030236","article-title":"Patients\u2019 preferences and willingness to pay for solid forms of oral medications-results of the discrete choice experiment in polish outpatients","volume":"12","author":"Kurczewska-Michalak","year":"2020","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100161_bib76","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0897190017710524","article-title":"Medication adherence in older patients with dementia: a systematic literature review","volume":"31","author":"El-Saifi","year":"2018","journal-title":"J Pharm Pract"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100161_bib77","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00228-021-03097-x","article-title":"Global prevalence and types of complementary and alternative medicines use amongst adults with diabetes: systematic review and meta-analysis","volume":"77","author":"Alzahrani","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100161_bib78","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1161\/HYPERTENSIONAHA.124.23254","article-title":"Association of high blood pressure with post-traumatic stress disorder in Ukrainian women refugees","volume":"81","author":"Shalimova","year":"2024","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100161_bib79","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","article-title":"Patients\u2019 beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness","volume":"47","author":"Horne","year":"1999","journal-title":"J Psychosom Res"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100161_bib80","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1586\/eci.12.23","article-title":"Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature","volume":"8","author":"van den Bemt","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100161_bib81","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/HJH.0000000000002783","article-title":"Therapeutic inertia in the management of hypertension in primary care","volume":"39","author":"Ali","year":"2021","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100161_bib82","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/00004872-200406000-00024","article-title":"Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study","volume":"22","author":"Ferrari","year":"2004","journal-title":"J Hypertens"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100161_bib83","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.034787","article-title":"Evaluation of blood pressure control, medication adherence, and therapeutic inertia in US patients with hypertension prescribed multiple antihypertensives","volume":"14","author":"Mohl","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib84","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/s12872-024-04109-1","article-title":"Therapeutic inertia and contributing factors among ambulatory patients with hypertension","volume":"24","author":"Niriayo","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100161_bib85","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41371-025-01067-9","article-title":"The association of area deprivation index and blood pressure control and therapeutic inertia among older adults with hypertension","volume":"39","author":"Saban","year":"2025","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.pharmr.2026.100161_bib86","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.2147\/RMHP.S327644","article-title":"Effect of the COVID-19 pandemic and other predictors of true therapeutic inertia on patients with hypertension in a Primary Care Clinic in Thailand","volume":"14","author":"Sornsenee","year":"2021","journal-title":"Risk Manag Healthc Policy"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100161_bib87","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031574","article-title":"Association between self-reported medication adherence and therapeutic inertia in hypertension: a secondary analysis of Sprint (systolic blood pressure intervention trial)","volume":"13","author":"Jacobs","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100161_bib88","doi-asserted-by":"crossref","first-page":"480","DOI":"10.37765\/ajmc.2021.88775","article-title":"Promoters of therapeutic inertia in managing hypertension: a consensus-based study","volume":"27","author":"Shawahna","year":"2021","journal-title":"Am J Manag Care"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100161_bib89","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archinte.162.4.413","article-title":"Physician-related barriers to the effective management of uncontrolled hypertension","volume":"162","author":"Oliveria","year":"2002","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100161_bib90","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/jamacardio.2020.2739","article-title":"Association of low-dose triple combination therapy with therapeutic inertia and prescribing patterns in patients with hypertension: a secondary analysis of the TRIUMPH trial","volume":"5","author":"Wang","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib91","article-title":"Analyzing adherence to prenatal supplement: does pill count measure up?","volume":"2010","author":"Appelgren","year":"2010","journal-title":"Int J Endocrinol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib92","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s13063-024-08209-3","article-title":"Registry-based randomised controlled trials: conduct, advantages and challenges-a systematic review","volume":"25","author":"Shiely","year":"2024","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib93","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.117.09739","article-title":"Detecting nonadherence to antihypertensive treatment: any time, anywhere?","volume":"70","author":"Hamdidouche","year":"2017","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100161_bib94","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/08037051.2017.1346458","article-title":"Heart rate is a useful marker of adherence to beta-blocker treatment in hypertension","volume":"26","author":"Koci\u00e1nov\u00e1","year":"2017","journal-title":"Blood Press"},{"key":"10.1016\/j.pharmr.2026.100161_bib95","doi-asserted-by":"crossref","DOI":"10.2147\/PPA.S576212","article-title":"Glucosuria as a biomarker of adherence to sodium-glucose co-transporter protein Type 2 inhibitors","volume":"20","author":"Escribano-Serrano","year":"2026","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib96","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1472-6963-12-270","article-title":"Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss","volume":"12","author":"Meddings","year":"2012","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib97","doi-asserted-by":"crossref","DOI":"10.1080\/08037051.2025.2513434","article-title":"Patient perceptions, motivations and barriers to treatment adherence in hypertension: results of a questionnaire-based survey in five European countries","volume":"34","author":"Burnier","year":"2025","journal-title":"Blood Press"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100161_bib98","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJM199404283301702","article-title":"The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis","volume":"330","author":"Weis","year":"1994","journal-title":"N Engl J Med"},{"issue":"8964","key":"10.1016\/j.pharmr.2026.100161_bib99","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(95)91090-5","article-title":"Directly observed therapy for tuberculosis: history of an idea","volume":"345","author":"Bayer","year":"1995","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100161_bib100","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.57187\/s.4238","article-title":"Video-Observed Therapy as an alternative to Directly-Observed Therapy for active tuberculosis: a prospective study of feasibility and acceptability by patients and nurses in a low-incidence high-income area","volume":"155","author":"Cantero","year":"2025","journal-title":"Swiss Med Wkly"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100161_bib101","doi-asserted-by":"crossref","first-page":"655","DOI":"10.5588\/ijtld.21.0170","article-title":"Real-world implementation of video-observed therapy in an urban TB program in the United States","volume":"25","author":"Perry","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100161_bib102","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jamainternmed.2019.1455","article-title":"Use of directly observed therapy to assess treatment adherence in patients with apparent treatment-resistant hypertension","volume":"179","author":"Ruzicka","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100161_bib103","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/HYPERTENSIONAHA.113.01452","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure","volume":"62","author":"Fadl Elmula","year":"2013","journal-title":"Hypertension"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100161_bib104","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.025879","article-title":"Nonadherence by serum drug analyses in resistant hypertension: 7-year follow-up of patients considered adherent by directly observed therapy","volume":"11","author":"Halvorsen","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100161_bib105","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/ajh\/hpad013","article-title":"Nonadherence is common in patients with apparent resistant hypertension: a systematic review and meta-analysis","volume":"36","author":"Bourque","year":"2023","journal-title":"Am J Hypertens"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100161_bib106","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1097\/HJH.0000000000001502","article-title":"Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis","volume":"35","author":"Durand","year":"2017","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100161_bib107","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/HYPERTENSIONAHA.117.09631","article-title":"Biochemical screening for nonadherence is associated with blood pressure reduction and improvement in adherence","volume":"70","author":"Gupta","year":"2017","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100161_bib108","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/HJH.0b013e32835e2286","article-title":"Resistant hypertension? Assessment of adherence by toxicological urine analysis","volume":"31","author":"Jung","year":"2013","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib109","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/HJH.0000000000003585","article-title":"Antihypertensive drug concentration measurement combined with personalized feedback in resistant hypertension: a randomized controlled trial","volume":"42","author":"Peeters","year":"2024","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib110","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002343","article-title":"Adherence to antihypertensive medication in treatment-resistant hypertension undergoing renal denervation","volume":"5","author":"Schmieder","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100161_bib111","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/heartjnl-2013-305063","article-title":"High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS\/MS) urine analysis","volume":"100","author":"Tomaszewski","year":"2014","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib112","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/HYPERTENSIONAHA.116.07464","article-title":"Evaluation of adherence should become an integral part of assessment of patients with apparently treatment-resistant hypertension","volume":"68","author":"Berra","year":"2016","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100161_bib113","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/ajh\/hpae075","article-title":"Therapeutic drug monitoring and the challenge of conducting trials to improve antihypertensive medication adherence","volume":"37","author":"Muntner","year":"2024","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib114","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/HYPERTENSIONAHA.121.17596","article-title":"Nonadherence in hypertension: how to develop and implement chemical adherence testing","volume":"79","author":"Lane","year":"2022","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/FTD.0000000000001145","article-title":"Sample matrices for mass spectrometry-based adherence monitoring: a systematic critical review","volume":"46","author":"Jacobs","year":"2024","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pharmr.2026.100161_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1452464","article-title":"Chemical adherence testing in the clinical management of hypertension: a scoping review","volume":"15","author":"Rabbitt","year":"2024","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100161_bib117","article-title":"Chemical adherence testing-guided intervention versus standard of care in patients with hypertension who are non-adherent to antihypertensive treatment in the UK (OUTREACH): a multicentre, randomised controlled trial","volume":"2","author":"Tomaszewski","year":"2026","journal-title":"Lancet Prim Care"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100161_bib118","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/clpt.2014.59","article-title":"Methods for measuring, enhancing, and accounting for medication adherence in clinical trials","volume":"95","author":"Vrijens","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib119","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/bcp.12942","article-title":"A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence","volume":"82","author":"El Alili","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100161_bib120","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.7833","article-title":"Effectiveness of digital medicines to improve clinical outcomes in patients with uncontrolled hypertension and type 2 diabetes: prospective, open-label, cluster-randomized pilot clinical trial-Label","volume":"19","author":"Frias","year":"2017","journal-title":"J Med Internet Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib121","first-page":"103","article-title":"Ingestible sensors and medication adherence: focus on use in serious mental illness","volume":"8","author":"Alipour","year":"2020","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.pharmr.2026.100161_bib122","article-title":"Ingestible electronic sensors to measure instantaneous medication adherence: a narrative review","volume":"8","author":"Chai","year":"2022","journal-title":"Digit Health"},{"key":"10.1016\/j.pharmr.2026.100161_bib123","article-title":"The estimands framework: a primer on the ICH E9(R1) addendum","volume":"384","author":"Kahan","year":"2024","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100161_bib124","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12272-013-0105-7","article-title":"Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia","volume":"36","author":"Park","year":"2013","journal-title":"Arch Pharm Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100161_bib126","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJMoa1913805","article-title":"Inclisiran for the treatment of heterozygous familial hypercholesterolemia","volume":"382","author":"Raal","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100161_bib127","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jat\/bkaa073","article-title":"Comprehensive drug screening of whole blood by LC-HRMS-MS in a forensic laboratory","volume":"45","author":"Stephenson","year":"2021","journal-title":"J Anal Toxicol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100161_bib128","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/FTD.0000000000000994","article-title":"Best practices to implement dried blood spot sampling for therapeutic drug monitoring in clinical practice","volume":"44","author":"Francke","year":"2022","journal-title":"Ther Drug Monit"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100161_bib129","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41587-019-0040-3","article-title":"Accessing analytes in biofluids for peripheral biochemical monitoring","volume":"37","author":"Heikenfeld","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"10491","key":"10.1016\/j.pharmr.2026.100161_bib130","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S0140-6736(25)00770-6","article-title":"SPIRIT 2025 statement: updated guideline for protocols of randomised trials","volume":"405","author":"Chan","year":"2025","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100161_bib131","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/2047487319864671","article-title":"Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy","volume":"27","author":"Ballantyne","year":"2020","journal-title":"Eur J Prev Cardiol"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100161_bib132","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1056\/NEJMc1612601","article-title":"Spironolactone metabolites in TOPCAT\u2014new insights into regional variation","volume":"376","author":"de Denus","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100161_bib133","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/JCP.0000000000000372","article-title":"Medication nonadherence, \u201cprofessional subjects,\u201d and apparent placebo responders: overlapping challenges for medications development","volume":"35","author":"McCann","year":"2015","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100161_bib134","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/clpt.2010.171","article-title":"Understanding forgiveness: minding and mining the gaps between pharmacokinetics and therapeutics","volume":"88","author":"Osterberg","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100161_bib135","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jcph.689","article-title":"Mitigating the effects of nonadherence in clinical trials","volume":"56","author":"Shiovitz","year":"2016","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib136","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s43441-024-00719-1","article-title":"Risk-based quality management: a case for centralized monitoring","volume":"59","author":"Stansbury","year":"2025","journal-title":"Ther Innov Regul Sci"},{"issue":"25","key":"10.1016\/j.pharmr.2026.100161_bib139","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehy377","article-title":"Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)","volume":"40","author":"Valgimigli","year":"2019","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/M18-0543","article-title":"ESPACOMP medication adherence reporting guideline (EMERGE)","volume":"169","author":"De Geest","year":"2018","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100161_bib141","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/bcp.14240","article-title":"How the EMERGE guideline on medication adherence can improve the quality of clinical trials","volume":"86","author":"Eliasson","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100161_bib142","first-page":"CD000011","article-title":"Interventions to enhance medication adherence","author":"Haynes","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100161_bib143","article-title":"Interventions for enhancing medication adherence","volume":"2014","author":"Nieuwlaat","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100161_bib144","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact","volume":"50","author":"Curran","year":"2012","journal-title":"Med Care"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100161_bib145","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1002\/bcp.70178","article-title":"Medication adherence during the run-in phase of clinical trials: a systematic review of methodological and reporting rigour","volume":"91","author":"Davies","year":"2025","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100161_bib146","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jclinepi.2014.06.008","article-title":"Adherence measurement and patient recruitment methods are poor in intervention trials to improve patient adherence","volume":"67","author":"Jeffery","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib147","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s13063-026-09717-0","article-title":"Guideline for the Measurement, Analysis and Reporting of Medication Adherence during the Run-in phase of clinical trials (MARMAR)","volume":"27","author":"Davies","year":"2026","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100161_bib148","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.2017.21903","article-title":"Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO extension","volume":"319","author":"Calvert","year":"2018","journal-title":"JAMA"},{"issue":"694","key":"10.1016\/j.pharmr.2026.100161_bib149","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3399\/bjgp20X709457","article-title":"Patient and public involvement in general practice research","volume":"70","author":"Bowers","year":"2020","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.pharmr.2026.100161_bib150","article-title":"Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis","volume":"363","author":"Crocker","year":"2018","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100161_bib151","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-111824","article-title":"Retention in trials: a qualitative evidence synthesis of studies reporting participant reasons for trial non-completion","volume":"16","author":"Murphy","year":"2026","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib152","article-title":"Correlation between objective habit metrics and objective medication adherence: retrospective study of 15,818 participants from clinical studies","volume":"14","author":"Pironet","year":"2025","journal-title":"Interact J Med Res"},{"issue":"7557","key":"10.1016\/j.pharmr.2026.100161_bib153","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","article-title":"A meta-analysis of the association between adherence to drug therapy and mortality","volume":"333","author":"Simpson","year":"2006","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib154","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/jep.12095","article-title":"Healthy adherer effect\u2014the pitfall in the interpretation of the effect of medication adherence on health outcomes","volume":"20","author":"Ladova","year":"2014","journal-title":"J Eval Clin Pract"},{"issue":"9502","key":"10.1016\/j.pharmr.2026.100161_bib155","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(05)67760-4","article-title":"Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial","volume":"366","author":"Granger","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pharmr.2026.100161_bib156","doi-asserted-by":"crossref","DOI":"10.1177\/2042018819844694","article-title":"Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia","volume":"10","author":"Khunti","year":"2019","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib157","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/medicina59010182","article-title":"Clinical inertia in the management of type 2 diabetes mellitus: a systematic review","volume":"59","author":"Almigbal","year":"2023","journal-title":"Medicina (Kaunas)"},{"issue":"25","key":"10.1016\/j.pharmr.2026.100161_bib158","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011121","article-title":"Clinical inertia in the pharmacological management of hypertension: a systematic review and meta-analysis","volume":"97","author":"Milman","year":"2018","journal-title":"Med (Baltim)"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib159","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3803\/EnM.2022.1649","article-title":"Overcoming therapeutic inertia as the Achilles\u2019 heel for improving suboptimal diabetes care: an integrative review","volume":"38","author":"Chew","year":"2023","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.pharmr.2026.100161_bib160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13098-020-00559-7","article-title":"Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review","volume":"12","author":"Andreozzi","year":"2020","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100161_bib161","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.HYP.0000200702.76436.4b","article-title":"Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals","volume":"47","author":"Okonofua","year":"2006","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100161_bib162","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s44360-026-00073-6","article-title":"Matching clinicians with clinical trials using AI","volume":"1","author":"Gao","year":"2026","journal-title":"Nat Health"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib163","doi-asserted-by":"crossref","first-page":"15","DOI":"10.18773\/austprescr.2024.001","article-title":"Therapeutic inertia","volume":"47","author":"Usherwood","year":"2024","journal-title":"Aust Prescr"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib164","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/jch.13150","article-title":"Pharmacist-physician collaborative care model and time to goal blood pressure in the uninsured population","volume":"20","author":"Dixon","year":"2018","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100161_bib165","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/HYPERTENSIONAHA.122.20292","article-title":"Effectiveness and cost-effectiveness of team-based care for hypertension: a meta-analysis and simulation study","volume":"80","author":"Bryant","year":"2023","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100161_bib166","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJMoa2508228","article-title":"Cabotegravir plus Rilpivirine for persons with HIV and adherence challenges","volume":"394","author":"Rana","year":"2026","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib167","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11906-025-01325-8","article-title":"Small interfering RNA therapy for the management and prevention of hypertension","volume":"27","author":"Ren","year":"2025","journal-title":"Curr Hypertens Rep"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100161_bib168","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008953","article-title":"PCSK9 inhibitors in lipid management of patients with diabetes mellitus and high cardiovascular risk: a review","volume":"7","author":"Handelsman","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100161_bib169","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/HYPERTENSIONAHA.124.22878","article-title":"Counteracting angiotensinogen small-interfering RNA-mediated antihypertensive effects with REVERSIR","volume":"81","author":"Ye","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmr.2026.100161_bib170","series-title":"Framework for Action on Interprofessional Education and Collaborative Practice","year":"2010"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib171","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12875-021-01595-6","article-title":"What do patients experience? Interprofessional collaborative practice for chronic conditions in primary care: an integrative review","volume":"23","author":"Davidson","year":"2022","journal-title":"BMC Prim Care"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100161_bib172","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/ACM.0000000000000603","article-title":"The patient-as-partner approach in health care: a conceptual framework for a necessary transition","volume":"90","author":"Karazivan","year":"2015","journal-title":"Acad Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib173","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/13561820.2024.2407073","article-title":"From classroom to collaboration: how pre-graduation interprofessional learning shapes health professional graduates\u2019 interactions in practice","volume":"39","author":"Evans","year":"2025","journal-title":"J Interprof Care"},{"issue":"9756","key":"10.1016\/j.pharmr.2026.100161_bib174","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0140-6736(10)61854-5","article-title":"Health professionals for a new century: transforming education to strengthen health systems in an interdependent world","volume":"376","author":"Frenk","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100161_bib175","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3109\/0142159X.2016.1173663","article-title":"A BEME systematic review of the effects of interprofessional education: BEME Guide No. 39: BEME Guide No. 39","volume":"38","author":"Reeves","year":"2016","journal-title":"Med Teach"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100161_bib176","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/0142159X.2018.1445207","article-title":"Interprofessional training: start with the youngest! A program for undergraduate healthcare students in Geneva, Switzerland","volume":"40","author":"van Gessel","year":"2018","journal-title":"Med Teach"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib177","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5334\/ijic.5588","article-title":"An overview of reviews on interprofessional collaboration in primary care: effectiveness","volume":"21","author":"Carron","year":"2021","journal-title":"Int J Integr Care"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100161_bib178","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.sapharm.2014.12.003","article-title":"Physicians and community pharmacists collaboration in primary care: a review of specific models","volume":"11","author":"Bardet","year":"2015","journal-title":"Res Social Adm Pharm"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib179","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/tbm\/ibx019","article-title":"Evaluating the effectiveness of behavior change techniques in health-related behavior: a scoping review of methods used","volume":"8","author":"Michie","year":"2018","journal-title":"Transl Behav Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib180","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12875-021-01391-2","article-title":"The association between self-efficacy and self-care in essential hypertension: a systematic review","volume":"22","author":"Tan","year":"2021","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.pharmr.2026.100161_bib181","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.2147\/PPA.S419277","article-title":"How is patient adherence possible? A novel mechanistic model of adherence based on humanities","volume":"17","author":"Reach","year":"2023","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100161_bib182","first-page":"64","article-title":"The power of active listening to address medication non-adherence during care transition: a case report of a polypharmacy patient with type 2 diabetes","volume":"13","author":"Solh Dost","year":"2025","journal-title":"Pharmacy (Basel)"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib183","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12939-025-02377-7","article-title":"Interprofessional collaboration between pharmacists and community health workers: a scoping review","volume":"24","author":"Bandiera","year":"2025","journal-title":"Int J Equity Health"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib184","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/eurjcn\/zvae172","article-title":"Nurses and allied professionals\u2019 engagement in clinical research-in-practice: a statement of the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology","volume":"24","author":"Fredericks","year":"2025","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"10339","key":"10.1016\/j.pharmr.2026.100161_bib185","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0140-6736(22)00325-7","article-title":"A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial","volume":"399","author":"Sun","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100161_bib186","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.sapharm.2015.12.007","article-title":"Examination of England\u2019s New Medicine Service (NMS) of complex health care interventions in community pharmacy","volume":"12","author":"Latif","year":"2016","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib187","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1186\/s12913-018-3509-8","article-title":"Implementation of an interprofessional medication adherence program for HIV patients: description of the process using the framework for the implementation of services in pharmacy","volume":"18","author":"Lelubre","year":"2018","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib188","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12875-023-02240-0","article-title":"Barriers and enablers to implementing interprofessional primary care teams: a narrative review of the literature using the consolidated framework for implementation research","volume":"25","author":"Grant","year":"2024","journal-title":"BMC Prim Care"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib189","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12909-025-06909-1","article-title":"Medication adherence in the curricula of future European physicians, pharmacists and nurses\u2014a cross-sectional survey","volume":"25","author":"Gottlieb","year":"2025","journal-title":"BMC Med Educ"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100161_bib190","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/13561820.2019.1693354","article-title":"Interprofessional education as a contributor to professional and interprofessional identities","volume":"39","author":"Haugland","year":"2025","journal-title":"J Interprof Care"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib191","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5334\/gh.1184","article-title":"Does collaboration between general practitioners and pharmacists improve risk factors for cardiovascular disease and diabetes? A systematic review and meta-analysis","volume":"18","author":"Chaudhri","year":"2023","journal-title":"Glob Heart"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100161_bib192","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/bcp.15325","article-title":"Partnership between patients and interprofessional healthcare providers along the multifaceted journey to medication adherence","volume":"89","author":"Schneider","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100161_bib193","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-070468","article-title":"Perceptions of conflicting information about long-term medications: a qualitative in-depth interview study of patients with chronic diseases in the Swiss ambulatory care system","volume":"13","author":"Santos","year":"2023","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100161_bib194","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-060083","article-title":"Patients\u2019 perceptions of conflicting information on chronic medications: a prospective survey in Switzerland","volume":"12","author":"Santos","year":"2022","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100161_bib195","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1016\/j.pec.2022.06.013","article-title":"Motivational interviewing to support medication adherence in adults with chronic conditions: systematic review of randomized controlled trials","volume":"105","author":"Papus","year":"2022","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.pharmr.2026.100161_bib196","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejim.2023.10.012","article-title":"From non-adherence to adherence: can innovative solutions resolve a longstanding problem?","volume":"119","author":"Kardas","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.pharmr.2026.100161_bib197","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1570359","article-title":"Clinical and economic consequences of medication nonadherence: a review of systematic reviews","volume":"16","author":"Achterbosch","year":"2025","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100161_bib198","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1080\/08870446.2022.2144923","article-title":"Medication nonadherence: health impact, prevalence, correlates and interventions","volume":"38","author":"Stewart","year":"2023","journal-title":"Psychol Health"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib199","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016982","article-title":"Economic impact of medication non-adherence by disease groups: a systematic review","volume":"8","author":"Cutler","year":"2018","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100161_bib200","first-page":"61","article-title":"The prevalence of unused medications in homes","volume":"7","author":"Makki","year":"2019","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.pharmr.2026.100161_bib201","article-title":"Analysis of medicines returned to pharmacies for disposal and estimation of the cost due to medicine wasting","volume":"5","author":"Romanelli","year":"2022","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib202","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1186\/s12889-021-11100-4","article-title":"Medicine storage, wastage, and associated determinants among urban households: a systematic review and meta-analysis of household surveys","volume":"21","author":"Jafarzadeh","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.pharmr.2026.100161_bib203","article-title":"Interventions to reduce the environmental impact of medicines: a UK perspective","volume":"4","author":"Cussans","year":"2021","journal-title":"J Clim Change Health"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100161_bib204","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192315798","article-title":"Household pharmaceutical waste disposal as a global problem-a review","volume":"19","author":"Rogowska","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.pharmr.2026.100161_bib205","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076200","article-title":"Reducing drug waste in hospitals","volume":"386","author":"Blackburn","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.pharmr.2026.100161_bib206","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2026.1788038","article-title":"From medicine cabinets to ecosystems: a Europe-wide assessment of household pharmaceutical waste disposal practices","volume":"17","author":"Kardas","year":"2026","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100161_bib207","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1574886315666200626164001","article-title":"Poor and unsatisfactory disposal of expired and unused pharmaceuticals: a global issue","volume":"15","author":"Nepal","year":"2020","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.pharmr.2026.100161_bib208","first-page":"71","article-title":"Disposal of unused drugs: knowledge and behavior among people around the world","volume":"240","author":"Paut Kusturica","year":"2017","journal-title":"Rev Environ Contam Toxicol"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100161_bib209","doi-asserted-by":"crossref","first-page":"8544","DOI":"10.3390\/ijerph18168544","article-title":"Household drug management practices of residents in a second-tier city in China: opportunities for reducing drug waste and environmental pollution","volume":"18","author":"Luo","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00267-019-01174-7","article-title":"Pharmaceutical household waste practices: preliminary findings from a case study in Poland","volume":"64","author":"Rogowska","year":"2019","journal-title":"Environ Manag"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100161_bib211","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae172","article-title":"Evaluation of antibiotics returned for safe disposal during and after a community pharmacy antibiotic amnesty campaign","volume":"6","author":"Hamilton","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.pharmr.2026.100161_bib212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2023.07.008","article-title":"The role of adherence in patients with chronic diseases","volume":"119","author":"Burnier","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100161_bib213","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/08037051.2022.2095254","article-title":"Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions","volume":"31","author":"Egan","year":"2022","journal-title":"Blood Press"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100161_bib214","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1742-1241.2009.01999.x","article-title":"Issues in blood pressure control and the potential role of single-pill combination therapies","volume":"63","author":"Burnier","year":"2009","journal-title":"Int J Clin Pract"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100161_bib215","doi-asserted-by":"crossref","first-page":"427","DOI":"10.5603\/ARM.a2021.0092","article-title":"Impact of inhalers used in the treatment of respiratory diseases on global warming","volume":"89","author":"Emeryk","year":"2021","journal-title":"Adv Respir Med"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100161_bib216","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/HJH.0000000000003793","article-title":"Effectiveness of digital health interventions on adherence and control of hypertension: a systematic review and meta-analysis","volume":"42","author":"Yap","year":"2024","journal-title":"J Hypertens"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100161_bib217","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1177\/07334648221120246","article-title":"The roles of busyness and daily routine in medication management behaviors among older adults","volume":"41","author":"Klinedinst","year":"2022","journal-title":"J Appl Gerontol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100161_bib218","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.jamda.2023.07.016","article-title":"Deprescribing interventions for older patients: a systematic review and meta-analysis","volume":"24","author":"Zhou","year":"2023","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.pharmr.2026.100161_bib219","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.734045","article-title":"Polypharmacy management in the older adults: a scoping review of available interventions","volume":"12","author":"Kurczewska-Michalak","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100161_bib220","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fcvm.2020.00049","article-title":"Hypertension and drug adherence in the elderly","volume":"7","author":"Burnier","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.pharmr.2026.100161_bib221","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1714049","article-title":"Medication non-adherence as a driver of pharmaceutical waste: integrating top-down policies with bottom-up practice","volume":"13","author":"Kardas","year":"2025","journal-title":"Front Public Health"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100161_bib222","article-title":"Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications","volume":"5","author":"Cross","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmr.2026.100161_bib223","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.892240","article-title":"Reimbursed medication adherence enhancing interventions in European countries: results of the EUREcA study","volume":"13","author":"\u00c1gh","year":"2022","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100161_bib224","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jval.2019.06.009","article-title":"Impact of star rating medication adherence measures on adherence for targeted and nontargeted medications","volume":"22","author":"Parekh","year":"2019","journal-title":"Value Health"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:57:36Z","timestamp":1792007856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699726000499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":222,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0031699726000499"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100161","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication adherence: An overlooked critical determinant of pharmacological effectiveness","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100161"}}